Notification and current-status evidence
The sent-report ledger records the first outgoing report at .
The recorded recipient is abuse@nicenic.net.
The latest stored availability evidence still shows the domain reachable; 5 months has elapsed since the first outgoing report.
ICANN RAA §3.18 describes registrar abuse-contact and handling obligations. This section records outgoing timestamps, listed recipients, case identifiers, and later availability. It does not by itself prove receipt, acknowledgement, investigation, remediation, or contractual non-compliance.
apharma[.]site
apharma.site のフィッシング・安全性チェック
“Apharma - Your Partner in Pharmaceutical Distribution”
apharma.site — 最後に確認されたアクティブな状態 (HTTP 200). 証拠の概要: VirusTotal 6/91 (alphaMountain.ai, Chong Lua Dao, CRDF, Gridinsoft, SOCRadar); PhishDestroy score 80/100. レジストラ: NiceNIC.
元のフォレンジック記録を保持するため、下の PhishDestroy AI 詳細分析は英語のままです。
The domain apharma.site is identified as a generic phishing domain impersonating a pharmaceutical distribution company. Currently, the domain is offline and not resolving to any active web content. The impersonation targets individuals and organizations seeking legitimate pharmaceutical products and services, potentially leading to financial loss or the compromising of sensitive information.
Infrastructure analysis reveals that apharma.site is registered through NiceNIC International Group Co., Limited. The domain resolves to the IP address 188.114.97.3 and was created on February 21, 2026. According to VirusTotal, 3 out of 95 security vendors have flagged this domain as malicious. The domain appears on 1 security blocklist and has a Gridinsoft trust score of 0/100, indicating a complete lack of trustworthiness. Despite the use of a Google Trust Services SSL certificate, which is often associated with legitimate websites, the presence of other suspicious indicators such as the low trust score and vendor flags suggests a high level of risk.
Given the current status of the domain being taken offline and blocked by PhishDestroy, it is recommended that all potential users and stakeholders refrain from accessing or engaging with this domain. Security teams should monitor for any reactivation of the domain and consider adding it to their organization's blocklists. Additionally, users should be educated on the signs of phishing activities and encouraged to verify the legitimacy of any pharmaceutical websites through official channels before providing any personal or financial information.
ネットワークセキュリティインテリジェンス Registrar context
脅威対応 Pipeline
公開ブロックリスト登録状況
保存済みキャプチャ
ドメイン・インテリジェンス
技術的な詳細DNS、SSL SAN、タイムスタンプ
ICANN OVERSIGHT
認定と RAA の背景
認定と RAA の背景
Registrar accreditation and DNS abuse obligations
For this gTLD, the registrar above operates under an ICANN accreditation agreement. The links below provide the official fee schedule and current DNS abuse compliance guidance.
Accreditation is a contract, not a safety certification.
RAA §3.18 establishes abuse-contact and handling requirements. This report can document stored outbound notices and later technical observations; it does not by itself establish receipt, investigation, remediation, or contractual non-compliance.
Latest Classified Outcome 2026-08-08 02:39:48 UTC
使用技術 · 3 identified
Performance monitoring tool that measures website speed from real users.
www.cloudflare.comWeb infrastructure and security company providing CDN, DDoS mitigation, and DNS services.
www.cloudflare.comThird major version of HTTP protocol, built on QUIC for faster, more reliable connections.
VirusTotalによる分析
アーカイブ済み証拠
サイト設定分析
証拠および外部報告書
PD-20260213-42AFC0 Recipient: abuse@nicenic.net このサイトによって何か影響を受けましたか?
アカウント資格情報、個人情報、支払い情報を入力した場合、またはこのドメインからファイルをダウンロードした場合は、すぐに対処してください。インシデントを報告し、自分自身を守るのに役立つリソースを以下に示します。
お住まいの地域の当局へ報告してください
サイバー犯罪の公式連絡先 または 苦情草稿を作成する → を取得するには、国を選択してください。
任意のドメインを確認する
保存されたブロックリスト、WHOIS、DNS、および公開スキャン証拠を使用した脅威分析
今すぐスキャンフィッシングを報告する
不審なドメインを当社の脅威データベースに報告してください — コミュニティを守りましょう
レポートリアルタイム脅威情報フィード
最近のフィッシングレポートと観察された可用性の変化
監視最新情報を入手し、安全を確保しましょう
リアルタイムの脅威を監視するか、誤検知だと思われる場合はこのリストに異議を申し立ててください